Vaccine Multican 8 for dogs 1 dose / 2 vials liquid + dry component
DESCRIPTION
Multican-8 is a vaccine against plague, adenovirus infections, parvovirus and coronavirus enteritis, leptospirosis and canine rabies. In appearance, the lyophilized component is a dry homogeneous fine-porous mass of yellow-pink color. The liquid component is a transparent or slightly opalescent liquid, the color of which can vary from light yellow to pink with a gray-white sediment at the bottom of the bottle of varying intensity, breaking up into a homogeneous suspension when shaken.
COMPOSITION
The dry component - lyophilized mass - is made from attenuated industrial strains of canine plague virus, canine adenovirus type 2, parvovirus and canine coronavirus with drying medium.
The liquid component - suspension for injection - is made from industrial inactivated strains of leptospira serogroups Icterohaemorrhagiae, Canicola and Grippotyphosa, industrial inactivated strain of rabies virus with adjuvant making up no more than 10% of the vaccine volume.
BIOLOGICAL PROPERTIES
The vaccine Multican-8 induces the formation of an immune response in dogs to plague, adenovirus infections, parvovirus, coronavirus enteritis, leptospirosis and rabies 2-3 weeks after immunization, lasting 6-8 months in young animals, and 12-15 months in adults.
One immunizing dose of the vaccine contains at least: canine distemper virus - 103.5TCD50, canine adenovirus type 2 - 103.0TCD50, canine parvovirus - 103.0 HAU, canine coronavirus - 103.0TCD50, rabies virus - 1 ME, leptospira serogroups Icterohaemorrhagiae, Canicola, Grippotyphosa - 3x108 microbial cells.
The vaccine is harmless and areactogenic, has no medicinal properties.
DOSAGE AND APPLICATION
Vaccine Multican-8 is intended for the prevention of plague, adenovirus infections, parvovirus and coronavirus enteritis, leptospirosis and canine rabies.
Multican-8 is administered to puppies twice (at 8-10 weeks of age and after 21-28 days) intramuscularly into the thigh area at a dose of 2.0 ml.
Revaccination of puppies is carried out at the age of 10-12 months.
Dogs of small and decorative breeds are vaccinated at a dose of 1 ml.
Adult dogs are vaccinated once a year at a dose of 2 ml.
Before use, the vaccine is heated to a temperature of 36-38 В° C; during use, the vials with the vaccine are thoroughly shaken until a homogeneous homogeneous suspension is formed.
Before use, the lyophilized vaccine component is dissolved in 2 ml of the supplied diluent (liquid component). When applied, the precipitation of vaccine components is excluded. In the presence of insignificant non-breaking sediment, the vaccine is pipetted 3-5 times in the vial with a syringe until a uniform homogeneous suspension is obtained.
Vaccination is carried out in compliance with the rules of asepsis; only sterile materials and instruments are used for injection. A separate needle is used for each animal.
SPECIAL INSTRUCTIONS
There were no symptoms of plague, adenovirus infections, parvovirus and coronavirus enteritis, leptospirosis and rabies or other pathological signs in case of an overdose of the vaccine.
The features of the post-vaccination reaction during primary and subsequent vaccinations have not been established.
Violations of the vaccination schedule (timing) should be avoided, as this can lead to a decrease in the effectiveness of immunization of plague, adenovirus infections, parvovirus and coronavirus enteritis, leptospirosis and rabies in dogs. If the next vaccine injection is missed, it is necessary to immunize as soon as possible.
CONTRAINDICATIONS
It is forbidden to vaccinate clinically sick and / or weakened animals, dogs in the last month of pregnancy and in the first month after birth.
SIDE EFFECTS
When using the vaccine in accordance with this instruction, side effects and complications, as a rule, are not noted. A rapidly disappearing swelling may appear at the injection site. In case of manifestation in some animals of allergic reactions to the administration of the vaccine, antihistamines are used.
SHELF LIFE AND STORAGE
The shelf life of the vaccine is 18 months from the date of issue, subject to storage and transportation conditions. After the expiration date, the vaccine is not suitable for use.
The vaccine is stored and transported in a dry dark place at a temperature of 2 В° C to 8 В° C. Should be stored out of the reach of children.
PACKAGING
Dry and liquid components of the vaccine are packaged in 1.0 ml (1 dose) in vials or ampoules with a capacity of 3.0 ml. The vials are sealed with rubber stoppers, reinforced with aluminum caps, the ampoules are hermetically sealed. The vials (ampoules) with the vaccine are packed in cardboard (plastic) boxes or blisters. Each vaccine box contains instructions for its use.
Specifications
KolVUP
five
Manufacturer
Vetbiohim
Temperature regime
from +2 to +8
Teaser
the vaccine is used to prevent plague, adenovirus infections, parvovirus and coronavirus enteritis, leptospirosis and rabies